This Week’s Roundup Of Biologics News

Biohaven's BHV-1200 Demonstrates Effective Neutralization Of COVID-19 Variants  Biohaven Pharma Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates, today announced that a hyperimmune globulin mimic… read more

en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?